Drugs that contain Deoxycholic Acid
1. Kybella patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US8242294 | KYTHERA BIOPHARMS | Synthetic bile acid compositions and methods |
May, 2028
(4 years from now) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8846066 | KYTHERA BIOPHARMS | Methods and related compositions for reduction of fat and skin tightening |
Feb, 2025
(9 months from now) | |
| US8298556 | KYTHERA BIOPHARMS | Methods and related compositions for the non-surgical removal of fat |
Aug, 2025
(1 year, 3 months from now) | |
| US7754230 | KYTHERA BIOPHARMS | Methods and related compositions for reduction of fat |
Dec, 2027
(3 years from now) | |
| US7622130 | KYTHERA BIOPHARMS | Methods and compositions for the non-surgical removal of fat |
Dec, 2027
(3 years from now) | |
| US8883770 | KYTHERA BIOPHARMS | Synthetic bile acid compositions and methods |
Feb, 2028
(3 years from now) | |
| US8546367 | KYTHERA BIOPHARMS | Synthetic bile acid compositions and methods |
Feb, 2028
(3 years from now) | |
| US8461140 | KYTHERA BIOPHARMS | Synthetic bile acid compositions and methods |
Feb, 2028
(3 years from now) | |
| US9522155 | KYTHERA BIOPHARMS | Synthetic bile acid compositions and methods |
Feb, 2028
(3 years from now) | |
| US9949986 | KYTHERA BIOPHARMS | Synthetic bile acid compositions and methods |
Feb, 2028
(3 years from now) | |
| US9636349 | KYTHERA BIOPHARMS | Synthetic bile acid compositions and methods |
Feb, 2028
(3 years from now) | |
| US10500214 | KYTHERA BIOPHARMS | Formulations of deoxycholic acid and salts thereof |
Mar, 2030
(5 years from now) | |
| US8367649 | KYTHERA BIOPHARMS | Formulations of deoxycholic acid and salts thereof |
Mar, 2030
(5 years from now) | |
| US8653058 | KYTHERA BIOPHARMS | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
Mar, 2030
(5 years from now) | |
| US8101593 | KYTHERA BIOPHARMS | Formulations of deoxycholic acid and salts thereof |
Mar, 2030
(5 years from now) | |
Market Authorisation Date: 29 April, 2015
Treatment: Method for reduction of submental fat; Improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults by means of reducing submental fat volume as de...
Dosage: SOLUTION;SUBCUTANEOUS
How can I launch a generic of KYBELLA before it's drug patent expiration?
More Information on Dosage
KYBELLA family patents
